Takeshi Nishikawa Selected Research

Takeshi Nishikawa Research Topics

Disease

55	Neoplasms (Cancer) 11/2023 - 12/2002
38	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 02/2008
29	Rectal Neoplasms (Rectal Cancer) 05/2021 - 01/2014
20	Neoplasm Metastasis (Metastasis) 04/2020 - 06/2010
14	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2009
12	Ulcerative Colitis 07/2022 - 01/2015
10	Lymphatic Metastasis 01/2021 - 04/2012
9	Hyperglycemia 01/2016 - 01/2003
7	Atherosclerosis 01/2015 - 10/2004
6	Carcinoma (Carcinomatosis) 11/2023 - 04/2010
6	Hemorrhage 11/2020 - 11/2016
6	Peritoneal Neoplasms 01/2019 - 11/2015
5	Diabetes Complications 01/2016 - 01/2006
4	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 12/2016
4	Adenocarcinoma 06/2020 - 07/2012
4	Obesity 02/2017 - 01/2011
4	Type 2 Diabetes Mellitus (MODY) 12/2013 - 05/2003
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 05/2006
3	Carcinogenesis 07/2017 - 05/2015
3	Disease Progression 02/2017 - 11/2015
3	Stomach Neoplasms (Stomach Cancer) 04/2016 - 11/2015
3	Diabetic Nephropathies (Diabetic Nephropathy) 03/2015 - 10/2003
3	Insulin Resistance 01/2013 - 03/2007
2	Pulmonary Hypertension 08/2019 - 01/2018
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2019 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 03/2019 - 06/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 06/2010
2	Infections 01/2019 - 03/2006
2	Anastomotic Leak 11/2017 - 06/2015
2	Melanoma (Melanoma, Malignant) 08/2017 - 01/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2003
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 05/2006
6	Indicators and Reagents (Reagents)IBA 03/2024 - 05/2015
6	Messenger RNA (mRNA)IBA 01/2022 - 10/2003
6	Proteins (Proteins, Gene)FDA Link 03/2019 - 10/2003
6	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 03/2007
5	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 06/2010
5	Insulin (Novolin)FDA Link 11/2018 - 05/2006
5	Irinotecan (Camptosar)FDA LinkGeneric 06/2018 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2003
4	AlbuminsIBA 02/2021 - 05/2003
4	Superoxide DismutaseIBA 01/2021 - 01/2006
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2019 - 09/2015
4	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 07/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 11/2017
3	Capecitabine (Xeloda)FDA Link 06/2019 - 09/2015
3	Carcinoembryonic AntigenIBA 05/2019 - 06/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2016
3	Leucovorin (Folinic Acid)FDA Link 01/2019 - 09/2015
3	AntigensIBA 05/2017 - 02/2008
3	AntibodiesIBA 01/2017 - 11/2010
3	Hormones (Hormone)IBA 12/2014 - 12/2002
3	Metformin (Glucophage)FDA LinkGeneric 06/2010 - 01/2006
3	AMP-Activated Protein KinasesIBA 06/2010 - 01/2006
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2020
2	CatecholaminesIBA 06/2022 - 12/2002
2	RNA (Ribonucleic Acid)IBA 06/2022 - 02/2020
2	Fixatives (Pickling Agents)IBA 06/2022 - 01/2021
2	LyasesIBA 01/2022 - 01/2018
2	EnzymesIBA 01/2022 - 01/2018
2	lysophosphatidylinositolIBA 01/2022 - 05/2019
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022 - 01/2018
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 07/2017
2	Chloroquine (Aralen)FDA LinkGeneric 07/2019 - 07/2010
2	Imatinib Mesylate (Gleevec)FDA Link 06/2019 - 01/2017
2	A-factor (Streptomyces)IBA 07/2018 - 01/2018
2	Doublecortin-Like KinasesIBA 06/2018 - 03/2018
2	Dihydrotachysterol (AT 10)IBA 03/2018 - 03/2016
2	Leucine (L-Leucine)FDA Link 03/2018 - 12/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 03/2007
2	CarbohydratesIBA 05/2017 - 01/2017
2	AdiponectinIBA 02/2017 - 04/2012
2	CytokinesIBA 04/2016 - 01/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2015 - 05/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 05/2007
2	Cetuximab (Erbitux)FDA Link 01/2015 - 01/2014
2	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2014 - 12/2002
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2014 - 12/2002
2	Vasopressins (Vasopressin)IBA 12/2014 - 12/2002
2	Apolipoproteins E (ApoE)IBA 02/2013 - 02/2009
2	isothiocyanic acidIBA 09/2010 - 02/2010
2	sulforaphaneIBA 09/2010 - 02/2010
2	PPAR gammaIBA 08/2010 - 05/2007

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 09/2020 - 06/2012
21	Therapeutics 11/2020 - 09/2007
18	Chemoradiotherapy 05/2021 - 01/2014
10	Neoadjuvant Therapy 01/2021 - 07/2012
9	Lymph Node Excision (Lymph Node Dissection) 07/2021 - 04/2016
7	Adjuvant Chemotherapy 06/2019 - 11/2013
7	Radiotherapy 03/2018 - 07/2012
6	Colectomy 07/2021 - 01/2017
5	Restorative Proctocolectomy 07/2022 - 01/2015
4	Ileostomy 08/2019 - 11/2017
2	Colostomy 08/2019 - 12/2016
2	Length of Stay 01/2018 - 12/2016
2	Immunotherapy 08/2017 - 02/2008
2	Operative Time 05/2017 - 06/2015
2	Exercise Therapy (Therapy, Exercise) 01/2017 - 12/2016
2	Proctectomy 01/2016 - 01/2014